131st MAINE LEGISLATURE
LD 1829 LR 735(04)
An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing
Fiscal Note for Senate Amendment " " to Committee Amendment "A"
Sponsor: Sen. Rotundo of Androscoggin
Fiscal Note Required: Yes
             
Fiscal Note
FY 2023-24 FY 2024-25 Projections  FY 2025-26 Projections  FY 2026-27
Net Cost (Savings)
General Fund $0 ($1,336,343) ($1,147,961) ($1,160,160)
Appropriations/Allocations
General Fund $0 $0 ($1,147,961) ($1,160,160)
Transfers
General Fund $0 $1,336,343 $0 $0
Other Special Revenue Funds $0 ($1,336,343) $0 $0
Fiscal Detail and Notes
This amendment removes the ongoing General Fund appropriations to the Office of Affordable Health Care beginning in fiscal year 2024-25 and replaces it with a one-time General Fund appropriation to the Office of Affordable Health Care of $1,336,343 in fiscal year 2024-25 to establish one limited-period Public Service Coordinator II position, one limited-period Planner II position and for contracts to administer the new requirements of the Maine Prescription Drug Affordability Board.

The amendment also adds a transfer of $1,336,343 from the Department of Professional and Financial Regulation, Bureau of Financial Institutions, Other Special Revenue Funds account to the Unappropriated Surplus of the General Fund.